Guideline on haemoglobin cutoffs to define anaemia in individuals and populations / World Health Organization.

Format:

Book

Author/Creator:

World Health Organization, author, issuing body.

Language:

English

Subjects (All):

Hemoglobin.

Physical Description:

1 online resource (1 PDF file (xix, 57 pages))

Place of Publication:

Geneva : World Health Organization, 2024.

Summary:

Appropriate guidelines for measuring haemoglobin and defining anaemia are crucial for both clinical and public health medicine but require consideration of a range of complexities across different populations. The objective of this guideline is to provide updated, clear, evidence-informed normative statements on the use of haemoglobin concentrations to assess anaemia and on the best approaches in its measurement in individuals and populations. The purpose of the guideline is to improve the diagnosis of anaemia, grounded in gender, equity and human rights approaches, with the aim of leaving no one behind, thereby informing the development of nutrition and health policies. The normative statements in this guideline are intended for a wide audience, including policy-makers, their expert advisers, and technical and programme staff at ministries and organizations involved in the design, implementation, and scaling-up of actions for addressing anaemia. Other end-users of the guideline include nongovernmental and other organizations and professional societies involved in the planning and management of anaemia actions, as well as health professionals including clinicians, managers of nutrition and health programmes, national blood services, and public health policy-makers in all settings.

Contents:

Acknowledgements

Abbreviations

Executive summary

Background

Scope and purpose

Objectives

History of this guideline

Existing WHO documents related to this new guideline

Technical meetings convened for developing this guideline

Summary of the evidence

Question 1

Question 2

Question 3

Question 4

Question 5

Dissemination, implementation, and ethical considerations

Dissemination

Equity, human rights, and implementation considerations

Regulatory considerations

Ethical considerations

Monitoring and evaluation of guideline implementation

Guideline development process

Scoping the guideline, evidence appraisal, and decision-making

Management of competing interests

Plans for updating the guideline

References

Annex 1. GRADE summary of findings tables

Annex 2. Questions in PICO format

Annex 3. Summary of judgements

Annex 4. WHO Steering Committee

Annex 5. WHO Guideline Development Group

Annex 6. Systematic reviews and database analysis team

Annex 7. Peer-reviewers

Annex 8. WHO Secretariat.

Notes:

Description based on publisher supplied metadata and other sources.